Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA Advisory Panel Gives Tepid Support To New Daiichi Sankyo Drug
Forbes
Friday, October 31, 2014 - 2:01pm
tags:
FDA, Daiichi Sankyo, advisory panels, bloodthinners, Savaysa, edoxaban
Lawmaker Plans a Bill to Force Pharma to Disclose Compassionate Use Info
WSJ Pharmalot
Friday, October 31, 2014 - 9:58am
tags:
compassionate use guidelines
Those Old-Boy Networks Can Hinder Women From Climbing Biotech Ranks
WSJ Pharmalot
Friday, October 31, 2014 - 9:57am
tags:
biotech, women
Sanofi Said to Have Contacted AstraZeneca’s Soriot About CEO position
Bloomberg
Friday, October 31, 2014 - 9:55am
tags:
Sanofi, Pharma CEOs, Pascal Soriot
Orphan drugs a niche no longer
Medical Marketing and Media
Friday, October 31, 2014 - 9:40am
tags:
orphan drugs
It's Not Just You: FDA Regulatory Requirements Really Are Increasing
RAPS.org
Friday, October 31, 2014 - 9:35am
tags:
FDA, regulatory
Kimberly-Clark Accused Of Falsely Claiming Its Medical Wear Protects Against Ebola
Bidness Etc.
Friday, October 31, 2014 - 8:30am
tags:
Kimberly-Clark, ebola virus
AbbVie Raises Earnings Guidance After Humira Sales Surge
Bloomberg
Friday, October 31, 2014 - 8:23am
tags:
AbbVie, earnings, Humira
Theravance misses 3Q earnings and revenue expectations
Yahoo/AP
Friday, October 31, 2014 - 8:18am
tags:
Theravance, earnings
Ziopharm posts 3Q loss
Yahoo/AP
Friday, October 31, 2014 - 8:13am
tags:
earnings, Ziopharm
Feeling Dissed, Amgen Sues After Sandoz Abandons the BPCIA Patent Dance Procedures for NEUPOGEN Biosimilar; Alleges Unfair Competition, Patent Infringement, and Theft
FDA Law Blog
Thursday, October 30, 2014 - 5:43pm
tags:
Amgen, Sandoz, Neupogen, biosimilars
Microsoft Unveils Fitness Gadget, Health Tracking
Drug Discovery and Development
Thursday, October 30, 2014 - 5:36pm
tags:
Microsoft, devices, mHealth
3 Pharma Companies Fighting Obesity
Yahoo/Benzinga
Thursday, October 30, 2014 - 5:33pm
tags:
obesity, Orexigen, Arena, Vivus
Masimo Beats Q3 Earnings Estimates, Cuts Revenue Outlook
Yahoo/Zacks.com
Thursday, October 30, 2014 - 5:32pm
tags:
Masimo, earnings, devices
Avanir Inroads in Alzheimer’s Justify Offers: Real M&A
Bloomberg
Thursday, October 30, 2014 - 12:22pm
tags:
M&A, Avanir, Alzheimer's disease, Lundbeck, Eli Lilly, Mallinckrodt, Shire
Bayer Raises Forecast on New Drugs, Consumer-Health Unit
Bloomberg
Thursday, October 30, 2014 - 12:21pm
tags:
Bayer, consumer health, earnings
Did Novartis Make a Ham-Handed Move to Promote an Antibiotic for Pigs?
WSJ Pharmalot
Thursday, October 30, 2014 - 12:18pm
tags:
Novartis, animal health, antibiotics, antibiotic resistance
Chris Viehbacher leaving Sanofi without a U.S.-style windfall
Fierce Biotech
Thursday, October 30, 2014 - 12:16pm
tags:
Chris Viehbacher, Sanofi
Acorda posts 3Q revenue of $106 million, result beats expectations
Yahoo/AP
Thursday, October 30, 2014 - 12:15pm
tags:
Acorda Therapeutics, earnings
Perrigo Said in Exclusive Talks to Acquire Omega Pharma
Bloomberg/Businessweek
Thursday, October 30, 2014 - 12:13pm
tags:
Perrigo, Omega Pharma, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.